Form 13-F position report

CARIS LIFE SCIENCES INC COM

Reported by Alyeska Investment Group L P

CAI CUSIP 142152107 Manager CIK 0001453072

First reported at 376,000 shares this quarter.

New
% of reported 13F value 0.04% This manager · Q2 2025
Shares 376,000 Quarter-end amount reported
Reported value $10,046,720 Fair value at quarter end
Consecutive quarters held 1 Through Q2 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-06-30 10046720
2025-09-30 33307398
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for CARIS LIFE SCIENCES INC COM held by Alyeska Investment Group L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -1,101,071 (-100.0%) 0 $0 2026-02-13
Q3 2025 Added 1,101,071 +725,071 (192.8%) 0.1% $33,307,398 2025-11-17
Q2 2025 New 376,000 +376,000 (0.0%) 0.04% $10,046,720 2025-08-14

Who else reported the position

117 managers reported CARIS LIFE SCIENCES INC COM for Q2 2025.

Managers reporting CARIS LIFE SCIENCES INC COM in Q2 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Sixth Street Partners Management Company L P New 24,385,399 +24,385,399 51.71% $651,577,861 1 qtr
COATUE MANAGEMENT LLC New 10,142,198 +10,142,198 0.75% $270,999,531 1 qtr
FMR LLC New 8,631,545 +8,631,545 0.01% $230,634,883 1 qtr
BRAIDWELL LP New 7,316,142 +7,316,142 6.69% $195,487,315 1 qtr
T Rowe Price Investment Management Inc New 7,303,987 +7,303,987 0.12% $195,163,000 1 qtr
PRICE T ROWE ASSOCIATES INC MD New 6,760,804 +6,760,804 0.02% $180,649,000 1 qtr
Neuberger Berman Group LLC New 6,239,520 +6,239,520 0.13% $166,719,974 1 qtr
Silver Lake Group L L C New 5,291,006 +5,291,006 2.81% $141,375,680 1 qtr
MILLENNIUM MANAGEMENT LLC New 3,513,176 +3,513,176 0.05% $93,872,063 1 qtr
ORBIMED ADVISORS LLC New 3,034,858 +3,034,858 2.03% $81,091,406 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2025
Filed
August 14, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
376,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.